Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090363
Status:
COMPLETED
Last Update Posted:
2013-01-08
First Post:
2004-08-25
Brief Title:
ZD4054 Zibotentan in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen PSA
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-08
Completion Date Type:
ACTUAL
First Submit Date:
2004-08-25
First Submit QC Date:
August 27 2004
Study First Post Date:
2004-08-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-09-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2011-05-23
Disp First Submit QC Date:
May 23 2011
Disp First Post Date:
2011-06-01
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-01-03
Last Update Post Date:
2013-01-08
Last Update Post Date Type:
ESTIMATED